Earlier in vitro and in vivo experimental studies have already demonstrated the inhibitory effect of various SST analogs and cytotoxic SST analog AN-162 in breast cancer, lung cancer, glioblastoma, and colon carcinoma, suggesting the potential application of modern powerful cytotoxic SST analogs in patients suffering from malignant tumors [23,24,26,30,31,32,33,34,35]. This evidence concerns the gene SST and glioblastoma.